Literature DB >> 27138940

Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.

Dodie Pouniotis1, Choon-Kit Tang2,3, Vasso Apostolopoulos4, Geoffrey Pietersz5,6,7.   

Abstract

Cell-penetrating peptides (CPP) or membrane-translocating peptides such as penetratin from Antennapedia homeodomain or TAT from human immunodeficiency virus are useful vectors for the delivery of protein antigens or their cytotoxic (Tc) or helper (Th) T cell epitopes to antigen-presenting cells. Mice immunized with CPP containing immunogens elicit antigen-specific Tc and/or Th responses and could be protected from tumor challenges. In the present paper, we investigate the mechanism of class I and class II antigen presentation of ovalbumin covalently linked to penetratin (AntpOVA) by bone marrow-derived dendritic cells with the use of biochemical inhibitors of various pathways of antigen processing and presentation. Results from our study suggested that uptake of AntpOVA is via a combination of energy-independent (membrane fusion) and energy-dependent pathways (endocytosis). Once internalized by either mechanism, multiple tap-dependent or independent antigen presentation pathways are accessed while not completely dependent on proteasomal processing but involving proteolytic trimming in the ER and Golgi compartments. Our study provides an understanding on the mechanism of antigen presentation mediated by CPP and leads to greater insights into future development of vaccine formulations.

Entities:  

Keywords:  Antennapedia; Antp; CPP; Cell-penetrating peptides; Cytotoxic T cell epitope; Membrane-translocating peptide; Ovalbumin; TAT; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27138940     DOI: 10.1007/s12026-016-8799-5

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  71 in total

1.  A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway.

Authors:  G A Pietersz; W Li; V Apostolopoulos
Journal:  Vaccine       Date:  2001-01-08       Impact factor: 3.641

2.  Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus.

Authors:  Yunjung Cho; Sameh Basta; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis.

Authors:  Marjan M Fretz; Gerben A Koning; Enrico Mastrobattista; Wim Jiskoot; Gert Storm
Journal:  Biochim Biophys Acta       Date:  2004-10-11

4.  Cellular uptake of the Antennapedia homeodomain polypeptide by macropinocytosis.

Authors:  Xiaomo Wu; Walter Gehring
Journal:  Biochem Biophys Res Commun       Date:  2013-12-18       Impact factor: 3.575

Review 5.  Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.

Authors:  Feihu Wang; Yun Wang; Xiao Zhang; Wenjun Zhang; Shengrong Guo; Fang Jin
Journal:  J Control Release       Date:  2013-12-01       Impact factor: 9.776

6.  Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide.

Authors:  D T Kim; D J Mitchell; D G Brockstedt; L Fong; G P Nolan; C G Fathman; E G Engleman; J B Rothbard
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

Review 7.  Dendritic cell-targeted vaccines--hope or hype?

Authors:  Wolfgang Kastenmüller; Kathrin Kastenmüller; Christian Kurts; Robert A Seder
Journal:  Nat Rev Immunol       Date:  2014-09-05       Impact factor: 53.106

8.  Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.

Authors:  Naotaka Shibagaki; Mark C Udey
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

9.  Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments.

Authors:  P Sampath; T D Pollard
Journal:  Biochemistry       Date:  1991-02-19       Impact factor: 3.162

10.  Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes.

Authors:  Marie-Paule M Schutze-Redelmeier; Spencer Kong; Marcel B Bally; Jan P Dutz
Journal:  Vaccine       Date:  2004-05-07       Impact factor: 3.641

View more
  4 in total

Review 1.  Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.

Authors:  Morgan Grau; Paul R Walker; Madiha Derouazi
Journal:  Cell Mol Life Sci       Date:  2018-03-05       Impact factor: 9.261

2.  Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.

Authors:  Coralie M Backlund; Rebecca L Holden; Kelly D Moynihan; Daniel Garafola; Charlotte Farquhar; Naveen K Mehta; Laura Maiorino; Sydney Pham; J Bryan Iorgulescu; David A Reardon; Catherine J Wu; Bradley L Pentelute; Darrell J Irvine
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-01       Impact factor: 12.779

3.  Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.

Authors:  Nicole Brooks; Jennifer Hsu; Sandra Esparon; Dodie Pouniotis; Geoffrey A Pietersz
Journal:  Molecules       Date:  2018-09-02       Impact factor: 4.411

4.  Targeting Cross-Presentation as a Route to Improve the Efficiency of Peptide-Based Cancer Vaccines.

Authors:  Ben Wylie; Ferrer Ong; Hanane Belhoul-Fakir; Kristin Priebatsch; Heique Bogdawa; Anja Stirnweiss; Paul Watt; Paula Cunningham; Shane R Stone; Jason Waithman
Journal:  Cancers (Basel)       Date:  2021-12-08       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.